Strides Pharma Science submits unaudited financial results

30 Jan 2020 Evaluate

Strides Pharma Science has informed about submission of the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter and nine months ended December 31, 2019, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard. The board meeting commenced at 08:00 hrs and concluded at 09:00 hrs. 

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

875.00 5.60 (0.64%)
20-Jan-2026 11:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1653.90
Dr. Reddys Lab 1170.15
Cipla 1390.00
Zydus Lifesciences 879.85
Lupin 2165.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×